Irinotecan((+)-Irinotecan) CAS:97682-44-5, is a potent topoisomerase I inhibitor that plays a crucial role in cancer therapy. By specifically targeting and binding to the topoisomerase I-DNA complex, Irinotecan effectively prevents the religation of the DNA strand, leading to the inhibition of DNA replication and transcription. This targeted mechanism of action results in the disruption of cancer cell growth and proliferation, making Irinotecan a valuable therapeutic option for the treatment of various malignancies.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.
